More General News
View Older Stories View Newer Stories-
AppLovin tumbles 15% after Culper Research discloses short position
-
Lilly plans to invest $27 billion in new US plants as Trump threatens pharmaceutical tariffs
-
Bernstein upgrades Alibaba on AI optimism
-
US drugmaker Merck to boost workforce in India, executive says
-
US will spend up to $1 billion to combat bird flu, USDA secretary says
-
Verisk forecasts 2025 profit below estimates on high interest cost
-
NRG Energy shares pop as Q4 profit comes ahead of estimates
-
Krispy Kreme cut to sell at Morgan Stanley as 2025 guidance 'materially worse'
-
Trump asks Apple to end diversity policies after shareholders vote in favor
-
TJX forecasts annual sales growth, profit below estimates on muted consumer spending
-
Nvidia earnings offer little cheer for tech shares
-
AI startup Bridgetown Research raises $19 million in latest funding
-
Stellantis shares slide lower on soft H2 results, loose guidance
-
Lucid shares jump on strong 2025 vehicle production outlook; CEO steps down
-
Auto1 Group shares spike on better-than-anticipated fourth-quarter earnings
-
AstraZeneca breast cancer drug shows positive results, shares up
-
GM approves new share buyback, dividend increase
-
3M to return $10 billion to shareholders, reiterates sales forecast
-
GM to increase dividend 25%, buy back another $6 billion of shares
-
Intuitive Machines embarks on second moon landing mission with Athena lander
-
Amazon debuts new Alexa voice assistant with AI overhaul
-
DeepSeek cuts off-peak pricing for developers by up to 75%
-
Cava Group's annual sales growth target falls short of estimates
-
Trump wants to sell $5 million gold cards to foreigners who will create US jobs
-
Intuit fiscal Q2 results top estimates, reiterates FY guidance; lifts dividend
-
First Solar shares down as Q4 profit miss, issues 2025 guidance below expectations
-
Lucid CEO steps down, company expects to more than double vehicle production this year
-
Warner Bros Discovery shuts three videogame studios, spokesperson says
-
Maze Therapeutics receives positive ratings following recent IPO
-
Starbucks (SBUX) to Outsource Some Tech Work After Corp. Shake-Up - Bloomberg
-
Two clusters of unknown illness kill 50 in Democratic Republic of Congo
-
Meta must face lawsuit claiming it prefers cheaper foreign workers
-
Snowflake target raised at Canaccord ahead of earnings
-
Wall Street bullish on Metsera following January IPO on obesity drug pipeline
-
Tesla's market value tumbles below $1 trillion as its Europe sales slump
-
Bank of America’s preview of 3M investor day
-
Wall Street analysts upbeat on CyberArk’s investor day targets
-
Apple shareholders vote to keep its diversity policies
-
Argus cuts Domino’s rating to hold on cost pressures, weak U.S. sales
-
Morgan Stanley bullish on Progressive, lifts EPS estimate
-
US Treasury's Bessent vows to re-privatize an economy that is 'brittle underneath'
-
JP Morgan cuts Tempus AI rating to ‘neutral’ after stock’s sharp rally
-
Lilly unveils higher vial doses of obesity drug that are cheaper than injector pen
-
Sempra shares slump after dour 2025 profit forecast on high costs
-
CDPQ to buy renewable power company Innergex in $10 billion deal
-
Microsoft invests in cloud data firm Veeam Software to build AI products
-
Thermo Fisher buys Solventum's purification and filtration business for $4.1 billion
-
American Tower beats fourth-quarter revenue estimates as demand recovers
-
Paypal shares up after earnings outlook
-
Donut chain Krispy Kreme unveils disappointing guidance, sending shares tumbling
